CytomX Therapeutics Inc (CTMX)
1.70
-0.05
(-2.86%)
USD |
NASDAQ |
May 31, 16:00
1.71
+0.01
(+0.59%)
After-Hours: 20:00
CytomX Therapeutics Cash and Short Term Investments (Quarterly): 150.28M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 150.28M |
December 31, 2023 | 174.51M |
September 30, 2023 | 194.11M |
June 30, 2023 | 180.86M |
March 31, 2023 | 204.50M |
December 31, 2022 | 193.65M |
September 30, 2022 | 194.29M |
June 30, 2022 | 228.16M |
March 31, 2022 | 262.53M |
December 31, 2021 | 305.23M |
September 30, 2021 | 236.29M |
June 30, 2021 | 266.18M |
March 31, 2021 | 393.80M |
December 31, 2020 | 316.12M |
September 30, 2020 | 321.08M |
June 30, 2020 | 346.40M |
March 31, 2020 | 247.92M |
December 31, 2019 | 296.14M |
September 30, 2019 | 325.71M |
Date | Value |
---|---|
June 30, 2019 | 349.14M |
March 31, 2019 | 396.60M |
December 31, 2018 | 436.13M |
September 30, 2018 | 464.56M |
June 30, 2018 | 335.15M |
March 31, 2018 | 361.48M |
December 31, 2017 | 374.11M |
September 30, 2017 | 331.28M |
June 30, 2017 | 335.92M |
March 31, 2017 | 162.52M |
December 31, 2016 | 181.94M |
September 30, 2016 | 178.46M |
June 30, 2016 | 195.80M |
March 31, 2016 | 180.64M |
December 31, 2015 | 186.71M |
September 30, 2015 | 113.69M |
June 30, 2015 | 125.37M |
December 31, 2014 | 64.40M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
150.28M
Minimum
Mar 2024
393.80M
Maximum
Mar 2021
259.35M
Average
255.23M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Amgen Inc | 9.708B |
Ocular Therapeutix Inc | 482.89M |
ACADIA Pharmaceuticals Inc | 470.52M |
Cytokinetics Inc | 618.96M |
Akebia Therapeutics Inc | 41.96M |